Shield Arming Itself With Axis For Cardio Diagnostics Market Campaign
This article was originally published in The Gray Sheet
Executive Summary
Shield Diagnostics Group PLC's proposed merger with Olso, Norway-based Axis Biochemicals ASA, is an attempt to combine the companies' cardiovascular disease diagnostics technology to be supplied to hospital labs with clinical chemistry or immunoassay analyzers, the firms said Jan. 18.